Neutrophil/lymphocyte ratio as a prognostic indicator of hepatic arterial infusion chemotherapy with arterial cisplatin plus continuous 5‐fluorouracil

Publisher： John Wiley & Sons Inc

E-ISSN： 1872-034x|45|7|755-763

ISSN： 1386-6346

Source： HEPATOLOGY RESEARCH, Vol.45, Iss.7, 2015-07, pp. : 755-763

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 9, 2015-09 ,pp. : 949-959

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hepatic Arterial Infusion Chemotherapy Using Low-Dose 5-Fluorouracil and Cisplatin for Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 78, Iss. 1, 2010-07 ,pp. : 148-153

Karger

Access to resources Recommend Favorite

Randomized, Phase II Study Comparing Interferon Combined with Hepatic Arterial Infusion of Fluorouracil plus Cisplatin and Fluorouracil Alone in Patients with Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 81, Iss. 5-6, 2011-11 ,pp. : 281-290

Karger

Access to resources Recommend Favorite

Adjuvant Hepatic Arterial Infusional Chemotherapy with 5-Fluorouracil and Cisplatin after Curative Resection of Hepatocellular Carcinoma

By  

Oncology, Vol. 81, Iss. 3-4, 2011-11 ,pp. : 184-191

Karger

Access to resources Recommend Favorite

Evaluation of the “assessment for continuous treatment with hepatic arterial infusion chemotherapy” scoring system in patients with advanced hepatocellular carcinoma

By  

HEPATOLOGY RESEARCH, Vol. 48, Iss. 3, 2018-02 ,pp. : E87-E97

John Wiley & Sons Inc

Access to resources Recommend Favorite